Theraclion S.A.
TCLIF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $8 | $8 | $7 | $7 |
| - Cash | $0 | $4,171 | $3,898 | $7,815 |
| + Debt | $0 | $1,296 | $1,624 | $1,951 |
| Enterprise Value | $8 | -$2,868 | -$2,267 | -$5,858 |
| Revenue | $982 | $1,069 | $442 | $841 |
| % Growth | -8.1% | 141.8% | -47.5% | – |
| Gross Profit | -$3,473 | -$4,036 | -$3,131 | -$415 |
| % Margin | -353.5% | -377.7% | -708.4% | -49.3% |
| EBITDA | -$3,176 | -$2,894 | -$2,774 | -$1,629 |
| % Margin | -323.3% | -270.9% | -627.5% | -193.6% |
| Net Income | -$2,990 | -$3,394 | -$2,363 | -$1,199 |
| % Margin | -304.3% | -317.6% | -534.6% | -142.5% |
| EPS Diluted | -0.065 | -0.073 | -0.052 | -0.026 |
| % Growth | 11.9% | -41.6% | -97.3% | – |
| Operating Cash Flow | – | -$1,401 | -$1,510 | -$1,059 |
| Capital Expenditures | – | -$57 | -$45 | $1,059 |
| Free Cash Flow | – | -$1,458 | -$1,555 | $0 |